APO Research
Talk to an analyst

APO RESEARCH · REPORT

Antipyretic and Analgesic Drugs

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Antipyretic and Analgesic Drugs Market Analysis and Forecast 2026-2032

22 December 2025200 pages

Choose your research edition.

Industry ResearchAntipyretic and Analgesic Drugs Industry Research Report 2026131 pages · $2,950 USDIndustry Growth & TrendsGlobal Antipyretic and Analgesic Drugs Industry Growth and Trends Forecast to 2032112 pages · $3,450 USDMarket StructureGlobal Antipyretic and Analgesic Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032192 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Antipyretic and Analgesic Drugs Market Outlook and Growth Opportunities 2026208 pages · $4,250 USDMarket Analysis & ForecastGlobal Antipyretic and Analgesic Drugs Market Analysis and Forecast 2026-2032200 pages · $4,950 USD

Market perspective

The global Antipyretic and Analgesic Drugs market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Antipyretic and Analgesic Drugs is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Antipyretic and Analgesic Drugs is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Antipyretic and Analgesic Drugs is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Antipyretic and Analgesic Drugs is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Antipyretic and Analgesic Drugs include Yuanhe Pharmaceutical, Xinhui Pharmaceutical, Topfond Pharmaceutical, Taile Pharmaceutical, Sanofi, Pfizer, Kys Pharm, China Resources Double-Crane Pharmaceutical and Huaan Pharmaceutical, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Antipyretic and Analgesic Drugs, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Antipyretic and Analgesic Drugs, also provides the sales of main regions and countries. Of the upcoming market potential for Antipyretic and Analgesic Drugs, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Antipyretic and Analgesic Drugs sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Antipyretic and Analgesic Drugs market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Antipyretic and Analgesic Drugs sales, projected growth trends, production technology, application and end-user industry.

Antipyretic and Analgesic Drugs Segment by Company

Yuanhe Pharmaceutical

Xinhui Pharmaceutical

Topfond Pharmaceutical

Taile Pharmaceutical

Sanofi

Pfizer

Kys Pharm

China Resources Double-Crane Pharmaceutical

Huaan Pharmaceutical

Hongxing Pharmaceutical

Heping Pharmaceutical

China National Medicines Guorui Pharmaceutical

Dingchang Pharmaceutical

Baotai Pharmaceutical

Bayer

SKPL

Mallinckrodt

Antipyretic and Analgesic Drugs Segment by Type

Paracetamol

Naproxen

Ibuprofen

Analgin

Aspirin

Others

Antipyretic and Analgesic Drugs Segment by Application

Hospital

Clinic

Antipyretic and Analgesic Drugs Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Antipyretic and Analgesic Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Antipyretic and Analgesic Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Antipyretic and Analgesic Drugs.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Antipyretic and Analgesic Drugs in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Antipyretic and Analgesic Drugs manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Antipyretic and Analgesic Drugs sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Antipyretic and Analgesic Drugs Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Paracetamol Major Manufacturers Table 3. Naproxen Major Manufacturers Table 4. Ibuprofen Major Manufacturers Table 5. Analgin Major Manufacturers Table 6. Aspirin Major Manufacturers Table 7. Others Major Manufacturers Table 8. Global Antipyretic and Analgesic Drugs Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 9. Hospital Major Manufacturers Table 10. Clinic Major Manufacturers Table 11. Antipyretic and Analgesic Drugs Industry Trends Table 12. Antipyretic and Analgesic Drugs Industry Drivers Table 13. Antipyretic and Analgesic Drugs Industry Opportunities and Challenges Table 14. Antipyretic and Analgesic Drugs Industry Restraints Table 15. Global Antipyretic and Analgesic Drugs Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 16. Global Antipyretic and Analgesic Drugs Revenue by Region (2021-2026) & (US$ Million) Table 17. Global Antipyretic and Analgesic Drugs Revenue by Region (2027-2032) & (US$ Million) Table 18. Global Antipyretic and Analgesic Drugs Revenue Market Share by Region (2021-2026) Table 19. Global Antipyretic and Analgesic Drugs Revenue Market Share by Region (2027-2032) Table 20. Global Antipyretic and Analgesic Drugs Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (k units) Table 21. Global Antipyretic and Analgesic Drugs Sales by Region (2021-2026) & (k units) Table 22. Global Antipyretic and Analgesic Drugs Sales by Region (2027-2032) & (k units) Table 23. Global Antipyretic and Analgesic Drugs Sales Market Share by Region (2021-2026) Table 24. Global Antipyretic and Analgesic Drugs Sales Market Share by Region (2027-2032) Table 25. Global Antipyretic and Analgesic Drugs Revenue by Manufacturers (US$ Million) & (2021-2026) Table 26. Global Antipyretic and Analgesic Drugs Revenue Market Share by Manufacturers (2021-2026) Table 27. Global Antipyretic and Analgesic Drugs Sales by Manufacturers (US$ Million) & (2021-2026) Table 28. Global Antipyretic and Analgesic Drugs Sales Market Share by Manufacturers (2021-2026) Table 29. Global Antipyretic and Analgesic Drugs Sales Price (US$/unit) of Manufacturers (2021-2026) Table 30. Global Antipyretic and Analgesic Drugs Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 31. Global Antipyretic and Analgesic Drugs Key Manufacturers Manufacturing Sites & Headquarters Table 32. Global Antipyretic and Analgesic Drugs Manufacturers, Product Type & Application Table 33. Global Antipyretic and Analgesic Drugs Manufacturers' Establishment Date Table 34. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 35. Global Antipyretic and Analgesic Drugs by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 36. Global Antipyretic and Analgesic Drugs Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 37. Global Antipyretic and Analgesic Drugs Revenue by Type (2021-2026) & (US$ Million) Table 38. Global Antipyretic and Analgesic Drugs Revenue by Type (2027-2032) & (US$ Million) Table 39. Global Antipyretic and Analgesic Drugs Revenue Market Share by Type (2021-2026) Table 40. Global Antipyretic and Analgesic Drugs Revenue Market Share by Type (2027-2032) Table 41. Global Antipyretic and Analgesic Drugs Sales by Type 2021 VS 2025 VS 2032 (k units) Table 42. Global Antipyretic and Analgesic Drugs Sales by Type (2021-2026) & (k units) Table 43. Global Antipyretic and Analgesic Drugs Sales by Type (2027-2032) & (k units) Table 44. Global Antipyretic and Analgesic Drugs Sales Market Share by Type (2021-2026) Table 45. Global Antipyretic and Analgesic Drugs Sales Market Share by Type (2027-2032) Table 46. Global Antipyretic and Analgesic Drugs Price by Type (2021-2026) & (US$/unit) Table 47. Global Antipyretic and Analgesic Drugs Price by Type (2027-2032) & (US$/unit) Table 48. Global Antipyretic and Analgesic Drugs Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 49. Global Antipyretic and Analgesic Drugs Revenue by Application (2021-2026) & (US$ Million) Table 50. Global Antipyretic and Analgesic Drugs Revenue by Application (2027-2032) & (US$ Million) Table 51. Global Antipyretic and Analgesic Drugs Revenue Market Share by Application (2021-2026) Table 52. Global Antipyretic and Analgesic Drugs Revenue Market Share by Application (2027-2032) Table 53. Global Antipyretic and Analgesic Drugs Sales by Application 2021 VS 2025 VS 2032 (k units) Table 54. Global Antipyretic and Analgesic Drugs Sales by Application (2021-2026) & (k units) Table 55. Global Antipyretic and Analgesic Drugs Sales by Application (2027-2032) & (k units) Table 56. Global Antipyretic and Analgesic Drugs Sales Market Share by Application (2021-2026) Table 57. Global Antipyretic and Analgesic Drugs Sales Market Share by Application (2027-2032) Table 58. Global Antipyretic and Analgesic Drugs Price by Application (2021-2026) & (US$/unit) Table 59. Global Antipyretic and Analgesic Drugs Price by Application (2027-2032) & (US$/unit) Table 60. Yuanhe Pharmaceutical Company Information Table 61. Yuanhe Pharmaceutical Business Overview Table 62. Yuanhe Pharmaceutical Antipyretic and Analgesic Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 63. Yuanhe Pharmaceutical Antipyretic and Analgesic Drugs Product Portfolio Table 64. Yuanhe Pharmaceutical Recent Development Table 65. Xinhui Pharmaceutical Company Information Table 66. Xinhui Pharmaceutical Business Overview Table 67. Xinhui Pharmaceutical Antipyretic and Analgesic Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 68. Xinhui Pharmaceutical Antipyretic and Analgesic Drugs Product Portfolio Table 69. Xinhui Pharmaceutical Recent Development Table 70. Topfond Pharmaceutical Company Information Table 71. Topfond Pharmaceutical Business Overview Table 72. Topfond Pharmaceutical Antipyretic and Analgesic Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 73. Topfond Pharmaceutical Antipyretic and Analgesic Drugs Product Portfolio Table 74. Topfond Pharmaceutical Recent Development Table 75. Taile Pharmaceutical Company Information Table 76. Taile Pharmaceutical Business Overview Table 77. Taile Pharmaceutical Antipyretic and Analgesic Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 78. Taile Pharmaceutical Antipyretic and Analgesic Drugs Product Portfolio Table 79. Taile Pharmaceutical Recent Development Table 80. Sanofi Company Information Table 81. Sanofi Business Overview Table 82. Sanofi Antipyretic and Analgesic Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 83. Sanofi Antipyretic and Analgesic Drugs Product Portfolio Table 84. Sanofi Recent Development Table 85. Pfizer Company Information Table 86. Pfizer Business Overview Table 87. Pfizer Antipyretic and Analgesic Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 88. Pfizer Antipyretic and Analgesic Drugs Product Portfolio Table 89. Pfizer Recent Development Table 90. Kys Pharm Company Information Table 91. Kys Pharm Business Overview Table 92. Kys Pharm Antipyretic and Analgesic Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 93. Kys Pharm Antipyretic and Analgesic Drugs Product Portfolio Table 94. Kys Pharm Recent Development Table 95. China Resources Double-Crane Pharmaceutical Company Information Table 96. China Resources Double-Crane Pharmaceutical Business Overview Table 97. China Resources Double-Crane Pharmaceutical Antipyretic and Analgesic Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 98. China Resources Double-Crane Pharmaceutical Antipyretic and Analgesic Drugs Product Portfolio Table 99. China Resources Double-Crane Pharmaceutical Recent Development Table 100. Huaan Pharmaceutical Company Information Table 101. Huaan Pharmaceutical Business Overview Table 102. Huaan Pharmaceutical Antipyretic and Analgesic Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 103. Huaan Pharmaceutical Antipyretic and Analgesic Drugs Product Portfolio Table 104. Huaan Pharmaceutical Recent Development Table 105. Hongxing Pharmaceutical Company Information Table 106. Hongxing Pharmaceutical Business Overview Table 107. Hongxing Pharmaceutical Antipyretic and Analgesic Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 108. Hongxing Pharmaceutical Antipyretic and Analgesic Drugs Product Portfolio Table 109. Hongxing Pharmaceutical Recent Development Table 110. Heping Pharmaceutical Company Information Table 111. Heping Pharmaceutical Business Overview Table 112. Heping Pharmaceutical Antipyretic and Analgesic Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 113. Heping Pharmaceutical Antipyretic and Analgesic Drugs Product Portfolio Table 114. Heping Pharmaceutical Recent Development Table 115. China National Medicines Guorui Pharmaceutical Company Information Table 116. China National Medicines Guorui Pharmaceutical Business Overview Table 117. China National Medicines Guorui Pharmaceutical Antipyretic and Analgesic Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 118. China National Medicines Guorui Pharmaceutical Antipyretic and Analgesic Drugs Product Portfolio Table 119. China National Medicines Guorui Pharmaceutical Recent Development Table 120. Dingchang Pharmaceutical Company Information Table 121. Dingchang Pharmaceutical Business Overview Table 122. Dingchang Pharmaceutical Antipyretic and Analgesic Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 123. Dingchang Pharmaceutical Antipyretic and Analgesic Drugs Product Portfolio Table 124. Dingchang Pharmaceutical Recent Development Table 125. Baotai Pharmaceutical Company Information Table 126. Baotai Pharmaceutical Business Overview Table 127. Baotai Pharmaceutical Antipyretic and Analgesic Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 128. Baotai Pharmaceutical Antipyretic and Analgesic Drugs Product Portfolio Table 129. Baotai Pharmaceutical Recent Development Table 130. Bayer Company Information Table 131. Bayer Business Overview Table 132. Bayer Antipyretic and Analgesic Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 133. Bayer Antipyretic and Analgesic Drugs Product Portfolio Table 134. Bayer Recent Development Table 135. SKPL Company Information Table 136. SKPL Business Overview Table 137. SKPL Antipyretic and Analgesic Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 138. SKPL Antipyretic and Analgesic Drugs Product Portfolio Table 139. SKPL Recent Development Table 140. Mallinckrodt Company Information Table 141. Mallinckrodt Business Overview Table 142. Mallinckrodt Antipyretic and Analgesic Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 143. Mallinckrodt Antipyretic and Analgesic Drugs Product Portfolio Table 144. Mallinckrodt Recent Development Table 145. North America Antipyretic and Analgesic Drugs Revenue by Type (2021-2026) & (US$ Million) Table 146. North America Antipyretic and Analgesic Drugs Revenue by Type (2027-2032) & (US$ Million) Table 147. North America Antipyretic and Analgesic Drugs Sales by Type (2021-2026) & (k units) Table 148. North America Antipyretic and Analgesic Drugs Sales by Type (2027-2032) & (k units) Table 149. North America Antipyretic and Analgesic Drugs Sales Price by Type (2021-2026) & (US$/unit) Table 150. North America Antipyretic and Analgesic Drugs Sales Price by Type (2027-2032) & (US$/unit) Table 151. North America Antipyretic and Analgesic Drugs Revenue by Application (2021-2026) & (US$ Million) Table 152. North America Antipyretic and Analgesic Drugs Revenue by Application (2027-2032) & (US$ Million) Table 153. North America Antipyretic and Analgesic Drugs Sales by Application (2021-2026) & (k units) Table 154. North America Antipyretic and Analgesic Drugs Sales by Application (2027-2032) & (k units) Table 155. North America Antipyretic and Analgesic Drugs Sales Price by Application (2021-2026) & (US$/unit) Table 156. North America Antipyretic and Analgesic Drugs Sales Price by Application (2027-2032) & (US$/unit) Table 157. North America Antipyretic and Analgesic Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 158. North America Antipyretic and Analgesic Drugs Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 159. North America Antipyretic and Analgesic Drugs Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 160. North America Antipyretic and Analgesic Drugs Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 161. North America Antipyretic and Analgesic Drugs Sales by Country (2021-2026) & (k units) Table 162. North America Antipyretic and Analgesic Drugs Sales by Country (2027-2032) & (k units) Table 163. North America Antipyretic and Analgesic Drugs Sales Price by Country (2021-2026) & (US$/unit) Table 164. North America Antipyretic and Analgesic Drugs Sales Price by Country (2027-2032) & (US$/unit) Table 165. United States Antipyretic and Analgesic Drugs Revenue (2021-2032) & (US$ Million) Table 166. Canada Antipyretic and Analgesic Drugs Revenue (2021-2032) & (US$ Million) Table 167. Mexico Antipyretic and Analgesic Drugs Revenue (2021-2032) & (US$ Million) Table 168. Europe Antipyretic and Analgesic Drugs Revenue by Type (2021-2026) & (US$ Million) Table 169. Europe Antipyretic and Analgesic Drugs Revenue by Type (2027-2032) & (US$ Million) Table 170. Europe Antipyretic and Analgesic Drugs Sales by Type (2021-2026) & (k units) Table 171. Europe Antipyretic and Analgesic Drugs Sales by Type (2027-2032) & (k units) Table 172. Europe Antipyretic and Analgesic Drugs Sales Price by Type (2021-2026) & (US$/unit) Table 173. Europe Antipyretic and Analgesic Drugs Sales Price by Type (2027-2032) & (US$/unit) Table 174. Europe Antipyretic and Analgesic Drugs Revenue by Application (2021-2026) & (US$ Million) Table 175. Europe Antipyretic and Analgesic Drugs Revenue by Application (2027-2032) & (US$ Million) Table 176. Europe Antipyretic and Analgesic Drugs Sales by Application (2021-2026) & (k units) Table 177. Europe Antipyretic and Analgesic Drugs Sales by Application (2027-2032) & (k units) Table 178. Europe Antipyretic and Analgesic Drugs Sales Price by Application (2021-2026) & (US$/unit) Table 179. Europe Antipyretic and Analgesic Drugs Sales Price by Application (2027-2032) & (US$/unit) Table 180. Europe Antipyretic and Analgesic Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 181. Europe Antipyretic and Analgesic Drugs Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 182. Europe Antipyretic and Analgesic Drugs Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 183. Europe Antipyretic and Analgesic Drugs Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 184. Europe Antipyretic and Analgesic Drugs Sales by Country (2021-2026) & (k units) Table 185. Europe Antipyretic and Analgesic Drugs Sales by Country (2027-2032) & (k units) Table 186. Europe Antipyretic and Analgesic Drugs Sales Price by Country (2021-2026) & (US$/unit) Table 187. Europe Antipyretic and Analgesic Drugs Sales Price by Country (2027-2032) & (US$/unit) Table 188. Germany Antipyretic and Analgesic Drugs Revenue (2021-2032) & (US$ Million) Table 189. France Antipyretic and Analgesic Drugs Revenue (2021-2032) & (US$ Million) Table 190. U.K. Antipyretic and Analgesic Drugs Revenue (2021-2032) & (US$ Million) Table 191. Italy Antipyretic and Analgesic Drugs Revenue (2021-2032) & (US$ Million) Table 192. Russia Antipyretic and Analgesic Drugs Revenue (2021-2032) & (US$ Million) Table 193. Spain Antipyretic and Analgesic Drugs Revenue (2021-2032) & (US$ Million) Table 194. Netherlands Antipyretic and Analgesic Drugs Revenue (2021-2032) & (US$ Million) Table 195. Switzerland Antipyretic and Analgesic Drugs Revenue (2021-2032) & (US$ Million) Table 196. Sweden Antipyretic and Analgesic Drugs Revenue (2021-2032) & (US$ Million) Table 197. Poland Antipyretic and Analgesic Drugs Revenue (2021-2032) & (US$ Million) Table 198. China Antipyretic and Analgesic Drugs Revenue by Type (2021-2026) & (US$ Million) Table 199. China Antipyretic and Analgesic Drugs Revenue by Type (2027-2032) & (US$ Million) Table 200. China Antipyretic and Analgesic Drugs Sales by Type (2021-2026) & (k units) Table 201. China Antipyretic and Analgesic Drugs Sales by Type (2027-2032) & (k units) Table 202. China Antipyretic and Analgesic Drugs Sales Price by Type (2021-2026) & (US$/unit) Table 203. China Antipyretic and Analgesic Drugs Sales Price by Type (2027-2032) & (US$/unit) Table 204. China Antipyretic and Analgesic Drugs Revenue by Application (2021-2026) & (US$ Million) Table 205. China Antipyretic and Analgesic Drugs Revenue by Application (2027-2032) & (US$ Million) Table 206. China Antipyretic and Analgesic Drugs Sales by Application (2021-2026) & (k units) Table 207. China Antipyretic and Analgesic Drugs Sales by Application (2027-2032) & (k units) Table 208. China Antipyretic and Analgesic Drugs Sales Price by Application (2021-2026) & (US$/unit) Table 209. China Antipyretic and Analgesic Drugs Sales Price by Application (2027-2032) & (US$/unit) Table 210. Asia Antipyretic and Analgesic Drugs Revenue by Type (2021-2026) & (US$ Million) Table 211. Asia Antipyretic and Analgesic Drugs Revenue by Type (2027-2032) & (US$ Million) Table 212. Asia Antipyretic and Analgesic Drugs Sales by Type (2021-2026) & (k units) Table 213. Asia Antipyretic and Analgesic Drugs Sales by Type (2027-2032) & (k units) Table 214. Asia Antipyretic and Analgesic Drugs Sales Price by Type (2021-2026) & (US$/unit) Table 215. Asia Antipyretic and Analgesic Drugs Sales Price by Type (2027-2032) & (US$/unit) Table 216. Asia Antipyretic and Analgesic Drugs Revenue by Application (2021-2026) & (US$ Million) Table 217. Asia Antipyretic and Analgesic Drugs Revenue by Application (2027-2032) & (US$ Million) Table 218. Asia Antipyretic and Analgesic Drugs Sales by Application (2021-2026) & (k units) Table 219. Asia Antipyretic and Analgesic Drugs Sales by Application (2027-2032) & (k units) Table 220. Asia Antipyretic and Analgesic Drugs Sales Price by Application (2021-2026) & (US$/unit) Table 221. Asia Antipyretic and Analgesic Drugs Sales Price by Application (2027-2032) & (US$/unit) Table 222. Asia Antipyretic and Analgesic Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 223. Asia Antipyretic and Analgesic Drugs Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 224. Asia Antipyretic and Analgesic Drugs Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 225. Asia Antipyretic and Analgesic Drugs Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 226. Asia Antipyretic and Analgesic Drugs Sales by Country (2021-2026) & (k units) Table 227. Asia Antipyretic and Analgesic Drugs Sales by Country (2027-2032) & (k units) Table 228. Asia Antipyretic and Analgesic Drugs Sales Price by Country (2021-2026) & (US$/unit) Table 229. Asia Antipyretic and Analgesic Drugs Sales Price by Country (2027-2032) & (US$/unit) Table 230. Japan Antipyretic and Analgesic Drugs Revenue (2021-2032) & (US$ Million) Table 231. South Korea Antipyretic and Analgesic Drugs Revenue (2021-2032) & (US$ Million) Table 232. India Antipyretic and Analgesic Drugs Revenue (2021-2032) & (US$ Million) Table 233. Australia Antipyretic and Analgesic Drugs Revenue (2021-2032) & (US$ Million) Table 234. Taiwan Antipyretic and Analgesic Drugs Revenue (2021-2032) & (US$ Million) Table 235. Southeast Asia Antipyretic and Analgesic Drugs Revenue (2021-2032) & (US$ Million) Table 236. SAMEA Antipyretic and Analgesic Drugs Revenue by Type (2021-2026) & (US$ Million) Table 237. SAMEA Antipyretic and Analgesic Drugs Revenue by Type (2027-2032) & (US$ Million) Table 238. SAMEA Antipyretic and Analgesic Drugs Sales by Type (2021-2026) & (k units) Table 239. SAMEA Antipyretic and Analgesic Drugs Sales by Type (2027-2032) & (k units) Table 240. SAMEA Antipyretic and Analgesic Drugs Sales Price by Type (2021-2026) & (US$/unit) Table 241. SAMEA Antipyretic and Analgesic Drugs Sales Price by Type (2027-2032) & (US$/unit) Table 242. SAMEA Antipyretic and Analgesic Drugs Revenue by Application (2021-2026) & (US$ Million) Table 243. SAMEA Antipyretic and Analgesic Drugs Revenue by Application (2027-2032) & (US$ Million) Table 244. SAMEA Antipyretic and Analgesic Drugs Sales by Application (2021-2026) & (k units) Table 245. SAMEA Antipyretic and Analgesic Drugs Sales by Application (2027-2032) & (k units) Table 246. SAMEA Antipyretic and Analgesic Drugs Sales Price by Application (2021-2026) & (US$/unit) Table 247. SAMEA Antipyretic and Analgesic Drugs Sales Price by Application (2027-2032) & (US$/unit) Table 248. SAMEA Antipyretic and Analgesic Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 249. SAMEA Antipyretic and Analgesic Drugs Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 250. SAMEA Antipyretic and Analgesic Drugs Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 251. SAMEA Antipyretic and Analgesic Drugs Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 252. SAMEA Antipyretic and Analgesic Drugs Sales by Country (2021-2026) & (k units) Table 253. SAMEA Antipyretic and Analgesic Drugs Sales by Country (2027-2032) & (k units) Table 254. SAMEA Antipyretic and Analgesic Drugs Sales Price by Country (2021-2026) & (US$/unit) Table 255. SAMEA Antipyretic and Analgesic Drugs Sales Price by Country (2027-2032) & (US$/unit) Table 256. Brazil Antipyretic and Analgesic Drugs Revenue (2021-2032) & (US$ Million) Table 257. Argentina Antipyretic and Analgesic Drugs Revenue (2021-2032) & (US$ Million) Table 258. Chile Antipyretic and Analgesic Drugs Revenue (2021-2032) & (US$ Million) Table 259. Colombia Antipyretic and Analgesic Drugs Revenue (2021-2032) & (US$ Million) Table 260. Peru Antipyretic and Analgesic Drugs Revenue (2021-2032) & (US$ Million) Table 261. Saudi Arabia Antipyretic and Analgesic Drugs Revenue (2021-2032) & (US$ Million) Table 262. Israel Antipyretic and Analgesic Drugs Revenue (2021-2032) & (US$ Million) Table 263. UAE Antipyretic and Analgesic Drugs Revenue (2021-2032) & (US$ Million) Table 264. Turkey Antipyretic and Analgesic Drugs Revenue (2021-2032) & (US$ Million) Table 265. Iran Antipyretic and Analgesic Drugs Revenue (2021-2032) & (US$ Million) Table 266. Egypt Antipyretic and Analgesic Drugs Revenue (2021-2032) & (US$ Million) Table 267. Key Raw Materials Table 268. Raw Materials Key Suppliers Table 269. Antipyretic and Analgesic Drugs Distributors List Table 270. Antipyretic and Analgesic Drugs Customers List Table 271. Research Programs/Design for This Report Table 272. Authors List of This Report Table 273. Secondary Sources Table 274. Primary Sources List of Figures Figure 1. Antipyretic and Analgesic Drugs Image Figure 2. Global Antipyretic and Analgesic Drugs Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Antipyretic and Analgesic Drugs Market Size Share 2021 VS 2025 VS 2032 Figure 4. Paracetamol Image Figure 5. Naproxen Image Figure 6. Ibuprofen Image Figure 7. Analgin Image Figure 8. Aspirin Image Figure 9. Others Image Figure 10. Global Antipyretic and Analgesic Drugs Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 11. Global Antipyretic and Analgesic Drugs Market Size Share 2021 VS 2025 VS 2032 Figure 12. Hospital Image Figure 13. Clinic Image Figure 14. Global Antipyretic and Analgesic Drugs Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 15. Global Antipyretic and Analgesic Drugs Revenue (2021-2032) & (US$ Million) Figure 16. Global Antipyretic and Analgesic Drugs Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 17. Global Antipyretic and Analgesic Drugs Revenue Market Share by Region: 2025 Versus 2032 Figure 18. Global Antipyretic and Analgesic Drugs Revenue Market Share by Region (2021-2032) Figure 19. Global Antipyretic and Analgesic Drugs Sales (2021-2032) & (k units) Figure 20. Global Antipyretic and Analgesic Drugs Sales by Region: 2021 VS 2025 VS 2032 (k units) Figure 21. Global Antipyretic and Analgesic Drugs Sales Market Share by Region (2021-2032) Figure 22. US & Canada & Mexico Antipyretic and Analgesic Drugs Sales YoY (2021-2032) & (k units) Figure 23. Europe Antipyretic and Analgesic Drugs Sales YoY (2021-2032) & (k units) Figure 24. China Antipyretic and Analgesic Drugs Sales YoY (2021-2032) & (k units) Figure 25. Asia (Excluding China) Antipyretic and Analgesic Drugs Sales YoY (2021-2032) & (k units) Figure 26. South America, Middle East and Africa Antipyretic and Analgesic Drugs Sales YoY (2021-2032) & (k units) Figure 27. Global Antipyretic and Analgesic Drugs Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 28. Global Antipyretic and Analgesic Drugs Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 29. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 30. Global Antipyretic and Analgesic Drugs Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 31. Global Antipyretic and Analgesic Drugs Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 32. Global Antipyretic and Analgesic Drugs Revenue Market Share by Type (2021-2032) Figure 33. Global Antipyretic and Analgesic Drugs Sales by Type (2021 VS 2025 VS 2032) & (k units) Figure 34. Global Antipyretic and Analgesic Drugs Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 35. Global Antipyretic and Analgesic Drugs Sales Market Share by Type (2021-2032) Figure 36. Global Antipyretic and Analgesic Drugs Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 37. Global Antipyretic and Analgesic Drugs Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 38. Global Antipyretic and Analgesic Drugs Revenue Market Share by Application (2021-2032) Figure 39. Global Antipyretic and Analgesic Drugs Sales by Application (2021 VS 2025 VS 2032) & (k units) Figure 40. Global Antipyretic and Analgesic Drugs Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 41. Global Antipyretic and Analgesic Drugs Sales Market Share by Application (2021-2032) Figure 42. North America Antipyretic and Analgesic Drugs Revenue Share by Type (2021-2032) Figure 43. North America Antipyretic and Analgesic Drugs Sales Share by Type (2021-2032) Figure 44. North America Antipyretic and Analgesic Drugs Revenue Share by Application (2021-2032) Figure 45. North America Antipyretic and Analgesic Drugs Sales Share by Application (2021-2032) Figure 46. North America Antipyretic and Analgesic Drugs Revenue Share by Country (2021-2032) Figure 47. North America Antipyretic and Analgesic Drugs Sales Share by Country (2021-2032) Figure 48. Europe Antipyretic and Analgesic Drugs Revenue Share by Type (2021-2032) Figure 49. Europe Antipyretic and Analgesic Drugs Sales Share by Type (2021-2032) Figure 50. Europe Antipyretic and Analgesic Drugs Revenue Share by Application (2021-2032) Figure 51. Europe Antipyretic and Analgesic Drugs Sales Share by Application (2021-2032) Figure 52. Europe Antipyretic and Analgesic Drugs Revenue Share by Country (2021-2032) Figure 53. Europe Antipyretic and Analgesic Drugs Sales Share by Country (2021-2032) Figure 54. China Antipyretic and Analgesic Drugs Revenue Share by Type (2021-2032) Figure 55. China Antipyretic and Analgesic Drugs Sales Share by Type (2021-2032) Figure 56. China Antipyretic and Analgesic Drugs Revenue Share by Application (2021-2032) Figure 57. China Antipyretic and Analgesic Drugs Sales Share by Application (2021-2032) Figure 58. Asia Antipyretic and Analgesic Drugs Revenue Share by Type (2021-2032) Figure 59. Asia Antipyretic and Analgesic Drugs Sales Share by Type (2021-2032) Figure 60. Asia Antipyretic and Analgesic Drugs Revenue Share by Application (2021-2032) Figure 61. Asia Antipyretic and Analgesic Drugs Sales Share by Application (2021-2032) Figure 62. Asia Antipyretic and Analgesic Drugs Revenue Share by Country (2021-2032) Figure 63. Asia Antipyretic and Analgesic Drugs Sales Share by Country (2021-2032) Figure 64. SAMEA Antipyretic and Analgesic Drugs Revenue Share by Type (2021-2032) Figure 65. SAMEA Antipyretic and Analgesic Drugs Sales Share by Type (2021-2032) Figure 66. SAMEA Antipyretic and Analgesic Drugs Revenue Share by Application (2021-2032) Figure 67. SAMEA Antipyretic and Analgesic Drugs Sales Share by Application (2021-2032) Figure 68. SAMEA Antipyretic and Analgesic Drugs Revenue Share by Country (2021-2032) Figure 69. SAMEA Antipyretic and Analgesic Drugs Sales Share by Country (2021-2032) Figure 70. Antipyretic and Analgesic Drugs Value Chain Figure 71. Manufacturing Cost Structure Figure 72. Antipyretic and Analgesic Drugs Production Mode & Process Figure 73. Direct Comparison with Distribution Share Figure 74. Distributors Profiles Figure 75. Years Considered Figure 76. Research Process Figure 77. Key Executives Interviewed

Scope & coverage.

Types
  • Paracetamol
  • Naproxen
  • Ibuprofen
  • Analgin
  • Aspirin
  • Others
Applications
  • Hospital
  • Clinic
Companies covered
  • Yuanhe Pharmaceutical
  • Xinhui Pharmaceutical
  • Topfond Pharmaceutical
  • Taile Pharmaceutical
  • Sanofi
  • Pfizer
  • Kys Pharm
  • China Resources Double-Crane Pharmaceutical
  • Huaan Pharmaceutical
  • Hongxing Pharmaceutical
  • Heping Pharmaceutical
  • China National Medicines Guorui Pharmaceutical
  • Dingchang Pharmaceutical
  • Baotai Pharmaceutical
  • Bayer
  • SKPL
  • Mallinckrodt

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Antipyretic and Analgesic Drugs Market by Type
  3. 1.2.1 Global Antipyretic and Analgesic Drugs Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Paracetamol
  5. 1.2.3 Naproxen
  6. 1.2.4 Ibuprofen
  7. 1.2.5 Analgin
  8. 1.2.6 Aspirin
  9. 1.2.7 Others
  10. 1.3 Antipyretic and Analgesic Drugs Market by Application
  11. 1.3.1 Global Antipyretic and Analgesic Drugs Market Size by Application, 2021 VS 2025 VS 2032
  12. 1.3.2 Hospital
  13. 1.3.3 Clinic
  14. 1.4 Assumptions and Limitations
  15. 1.5 Study Goals and Objectives
2 Antipyretic and Analgesic Drugs Market Dynamics
  1. 2.1 Antipyretic and Analgesic Drugs Industry Trends
  2. 2.2 Antipyretic and Analgesic Drugs Industry Drivers
  3. 2.3 Antipyretic and Analgesic Drugs Industry Opportunities and Challenges
  4. 2.4 Antipyretic and Analgesic Drugs Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Antipyretic and Analgesic Drugs Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Antipyretic and Analgesic Drugs Revenue by Region
  3. 3.2.1 Global Antipyretic and Analgesic Drugs Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Antipyretic and Analgesic Drugs Revenue by Region (2021-2026)
  5. 3.2.3 Global Antipyretic and Analgesic Drugs Revenue by Region (2027-2032)
  6. 3.2.4 Global Antipyretic and Analgesic Drugs Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Antipyretic and Analgesic Drugs Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Antipyretic and Analgesic Drugs Sales by Region
  9. 3.4.1 Global Antipyretic and Analgesic Drugs Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Antipyretic and Analgesic Drugs Sales by Region (2021-2026)
  11. 3.4.3 Global Antipyretic and Analgesic Drugs Sales by Region (2027-2032)
  12. 3.4.4 Global Antipyretic and Analgesic Drugs Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Antipyretic and Analgesic Drugs Revenue by Manufacturers
  2. 4.1.1 Global Antipyretic and Analgesic Drugs Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Antipyretic and Analgesic Drugs Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Antipyretic and Analgesic Drugs Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Antipyretic and Analgesic Drugs Sales by Manufacturers
  6. 4.2.1 Global Antipyretic and Analgesic Drugs Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Antipyretic and Analgesic Drugs Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Antipyretic and Analgesic Drugs Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Antipyretic and Analgesic Drugs Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Antipyretic and Analgesic Drugs Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Antipyretic and Analgesic Drugs Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Antipyretic and Analgesic Drugs Manufacturers, Product Type & Application
  13. 4.7 Global Antipyretic and Analgesic Drugs Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Antipyretic and Analgesic Drugs Market CR5 and HHI
  16. 4.8.2 2025 Antipyretic and Analgesic Drugs Tier 1, Tier 2, and Tier 3
5 Antipyretic and Analgesic Drugs Market by Type
  1. 5.1 Global Antipyretic and Analgesic Drugs Revenue by Type
  2. 5.1.1 Global Antipyretic and Analgesic Drugs Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Antipyretic and Analgesic Drugs Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Antipyretic and Analgesic Drugs Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Antipyretic and Analgesic Drugs Sales by Type
  6. 5.2.1 Global Antipyretic and Analgesic Drugs Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Antipyretic and Analgesic Drugs Sales by Type (2021-2032) & (k units)
  8. 5.2.3 Global Antipyretic and Analgesic Drugs Sales Market Share by Type (2021-2032)
  9. 5.3 Global Antipyretic and Analgesic Drugs Price by Type
6 Antipyretic and Analgesic Drugs Market by Application
  1. 6.1 Global Antipyretic and Analgesic Drugs Revenue by Application
  2. 6.1.1 Global Antipyretic and Analgesic Drugs Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Antipyretic and Analgesic Drugs Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Antipyretic and Analgesic Drugs Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Antipyretic and Analgesic Drugs Sales by Application
  6. 6.2.1 Global Antipyretic and Analgesic Drugs Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Antipyretic and Analgesic Drugs Sales by Application (2021-2032) & (k units)
  8. 6.2.3 Global Antipyretic and Analgesic Drugs Sales Market Share by Application (2021-2032)
  9. 6.3 Global Antipyretic and Analgesic Drugs Price by Application
7 Company Profiles
  1. 7.1 Yuanhe Pharmaceutical
  2. 7.1.1 Yuanhe Pharmaceutical Company Information
  3. 7.1.2 Yuanhe Pharmaceutical Business Overview
  4. 7.1.3 Yuanhe Pharmaceutical Antipyretic and Analgesic Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Yuanhe Pharmaceutical Antipyretic and Analgesic Drugs Product Portfolio
  6. 7.1.5 Yuanhe Pharmaceutical Recent Developments
  7. 7.2 Xinhui Pharmaceutical
  8. 7.2.1 Xinhui Pharmaceutical Company Information
  9. 7.2.2 Xinhui Pharmaceutical Business Overview
  10. 7.2.3 Xinhui Pharmaceutical Antipyretic and Analgesic Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Xinhui Pharmaceutical Antipyretic and Analgesic Drugs Product Portfolio
  12. 7.2.5 Xinhui Pharmaceutical Recent Developments
  13. 7.3 Topfond Pharmaceutical
  14. 7.3.1 Topfond Pharmaceutical Company Information
  15. 7.3.2 Topfond Pharmaceutical Business Overview
  16. 7.3.3 Topfond Pharmaceutical Antipyretic and Analgesic Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Topfond Pharmaceutical Antipyretic and Analgesic Drugs Product Portfolio
  18. 7.3.5 Topfond Pharmaceutical Recent Developments
  19. 7.4 Taile Pharmaceutical
  20. 7.4.1 Taile Pharmaceutical Company Information
  21. 7.4.2 Taile Pharmaceutical Business Overview
  22. 7.4.3 Taile Pharmaceutical Antipyretic and Analgesic Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Taile Pharmaceutical Antipyretic and Analgesic Drugs Product Portfolio
  24. 7.4.5 Taile Pharmaceutical Recent Developments
  25. 7.5 Sanofi
  26. 7.5.1 Sanofi Company Information
  27. 7.5.2 Sanofi Business Overview
  28. 7.5.3 Sanofi Antipyretic and Analgesic Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Sanofi Antipyretic and Analgesic Drugs Product Portfolio
  30. 7.5.5 Sanofi Recent Developments
  31. 7.6 Pfizer
  32. 7.6.1 Pfizer Company Information
  33. 7.6.2 Pfizer Business Overview
  34. 7.6.3 Pfizer Antipyretic and Analgesic Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 Pfizer Antipyretic and Analgesic Drugs Product Portfolio
  36. 7.6.5 Pfizer Recent Developments
  37. 7.7 Kys Pharm
  38. 7.7.1 Kys Pharm Company Information
  39. 7.7.2 Kys Pharm Business Overview
  40. 7.7.3 Kys Pharm Antipyretic and Analgesic Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 Kys Pharm Antipyretic and Analgesic Drugs Product Portfolio
  42. 7.7.5 Kys Pharm Recent Developments
  43. 7.8 China Resources Double-Crane Pharmaceutical
  44. 7.8.1 China Resources Double-Crane Pharmaceutical Company Information
  45. 7.8.2 China Resources Double-Crane Pharmaceutical Business Overview
  46. 7.8.3 China Resources Double-Crane Pharmaceutical Antipyretic and Analgesic Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 China Resources Double-Crane Pharmaceutical Antipyretic and Analgesic Drugs Product Portfolio
  48. 7.8.5 China Resources Double-Crane Pharmaceutical Recent Developments
  49. 7.9 Huaan Pharmaceutical
  50. 7.9.1 Huaan Pharmaceutical Company Information
  51. 7.9.2 Huaan Pharmaceutical Business Overview
  52. 7.9.3 Huaan Pharmaceutical Antipyretic and Analgesic Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  53. 7.9.4 Huaan Pharmaceutical Antipyretic and Analgesic Drugs Product Portfolio
  54. 7.9.5 Huaan Pharmaceutical Recent Developments
  55. 7.10 Hongxing Pharmaceutical
  56. 7.10.1 Hongxing Pharmaceutical Company Information
  57. 7.10.2 Hongxing Pharmaceutical Business Overview
  58. 7.10.3 Hongxing Pharmaceutical Antipyretic and Analgesic Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  59. 7.10.4 Hongxing Pharmaceutical Antipyretic and Analgesic Drugs Product Portfolio
  60. 7.10.5 Hongxing Pharmaceutical Recent Developments
  61. 7.11 Heping Pharmaceutical
  62. 7.11.1 Heping Pharmaceutical Company Information
  63. 7.11.2 Heping Pharmaceutical Business Overview
  64. 7.11.3 Heping Pharmaceutical Antipyretic and Analgesic Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  65. 7.11.4 Heping Pharmaceutical Antipyretic and Analgesic Drugs Product Portfolio
  66. 7.11.5 Heping Pharmaceutical Recent Developments
  67. 7.12 China National Medicines Guorui Pharmaceutical
  68. 7.12.1 China National Medicines Guorui Pharmaceutical Company Information
  69. 7.12.2 China National Medicines Guorui Pharmaceutical Business Overview
  70. 7.12.3 China National Medicines Guorui Pharmaceutical Antipyretic and Analgesic Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  71. 7.12.4 China National Medicines Guorui Pharmaceutical Antipyretic and Analgesic Drugs Product Portfolio
  72. 7.12.5 China National Medicines Guorui Pharmaceutical Recent Developments
  73. 7.13 Dingchang Pharmaceutical
  74. 7.13.1 Dingchang Pharmaceutical Company Information
  75. 7.13.2 Dingchang Pharmaceutical Business Overview
  76. 7.13.3 Dingchang Pharmaceutical Antipyretic and Analgesic Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  77. 7.13.4 Dingchang Pharmaceutical Antipyretic and Analgesic Drugs Product Portfolio
  78. 7.13.5 Dingchang Pharmaceutical Recent Developments
  79. 7.14 Baotai Pharmaceutical
  80. 7.14.1 Baotai Pharmaceutical Company Information
  81. 7.14.2 Baotai Pharmaceutical Business Overview
  82. 7.14.3 Baotai Pharmaceutical Antipyretic and Analgesic Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  83. 7.14.4 Baotai Pharmaceutical Antipyretic and Analgesic Drugs Product Portfolio
  84. 7.14.5 Baotai Pharmaceutical Recent Developments
  85. 7.15 Bayer
  86. 7.15.1 Bayer Company Information
  87. 7.15.2 Bayer Business Overview
  88. 7.15.3 Bayer Antipyretic and Analgesic Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  89. 7.15.4 Bayer Antipyretic and Analgesic Drugs Product Portfolio
  90. 7.15.5 Bayer Recent Developments
  91. 7.16 SKPL
  92. 7.16.1 SKPL Company Information
  93. 7.16.2 SKPL Business Overview
  94. 7.16.3 SKPL Antipyretic and Analgesic Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  95. 7.16.4 SKPL Antipyretic and Analgesic Drugs Product Portfolio
  96. 7.16.5 SKPL Recent Developments
  97. 7.17 Mallinckrodt
  98. 7.17.1 Mallinckrodt Company Information
  99. 7.17.2 Mallinckrodt Business Overview
  100. 7.17.3 Mallinckrodt Antipyretic and Analgesic Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  101. 7.17.4 Mallinckrodt Antipyretic and Analgesic Drugs Product Portfolio
  102. 7.17.5 Mallinckrodt Recent Developments
8 North America
  1. 8.1 North America Antipyretic and Analgesic Drugs Market Size by Type
  2. 8.1.1 North America Antipyretic and Analgesic Drugs Revenue by Type (2021-2032)
  3. 8.1.2 North America Antipyretic and Analgesic Drugs Sales by Type (2021-2032)
  4. 8.1.3 North America Antipyretic and Analgesic Drugs Price by Type (2021-2032)
  5. 8.2 North America Antipyretic and Analgesic Drugs Market Size by Application
  6. 8.2.1 North America Antipyretic and Analgesic Drugs Revenue by Application (2021-2032)
  7. 8.2.2 North America Antipyretic and Analgesic Drugs Sales by Application (2021-2032)
  8. 8.2.3 North America Antipyretic and Analgesic Drugs Price by Application (2021-2032)
  9. 8.3 North America Antipyretic and Analgesic Drugs Market Size by Country
  10. 8.3.1 North America Antipyretic and Analgesic Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Antipyretic and Analgesic Drugs Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Antipyretic and Analgesic Drugs Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe Antipyretic and Analgesic Drugs Market Size by Type
  2. 9.1.1 Europe Antipyretic and Analgesic Drugs Revenue by Type (2021-2032)
  3. 9.1.2 Europe Antipyretic and Analgesic Drugs Sales by Type (2021-2032)
  4. 9.1.3 Europe Antipyretic and Analgesic Drugs Price by Type (2021-2032)
  5. 9.2 Europe Antipyretic and Analgesic Drugs Market Size by Application
  6. 9.2.1 Europe Antipyretic and Analgesic Drugs Revenue by Application (2021-2032)
  7. 9.2.2 Europe Antipyretic and Analgesic Drugs Sales by Application (2021-2032)
  8. 9.2.3 Europe Antipyretic and Analgesic Drugs Price by Application (2021-2032)
  9. 9.3 Europe Antipyretic and Analgesic Drugs Market Size by Country
  10. 9.3.1 Europe Antipyretic and Analgesic Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Antipyretic and Analgesic Drugs Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Antipyretic and Analgesic Drugs Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China Antipyretic and Analgesic Drugs Market Size by Type
  2. 10.1.1 China Antipyretic and Analgesic Drugs Revenue by Type (2021-2032)
  3. 10.1.2 China Antipyretic and Analgesic Drugs Sales by Type (2021-2032)
  4. 10.1.3 China Antipyretic and Analgesic Drugs Price by Type (2021-2032)
  5. 10.2 China Antipyretic and Analgesic Drugs Market Size by Application
  6. 10.2.1 China Antipyretic and Analgesic Drugs Revenue by Application (2021-2032)
  7. 10.2.2 China Antipyretic and Analgesic Drugs Sales by Application (2021-2032)
  8. 10.2.3 China Antipyretic and Analgesic Drugs Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Antipyretic and Analgesic Drugs Market Size by Type
  2. 11.1.1 Asia Antipyretic and Analgesic Drugs Revenue by Type (2021-2032)
  3. 11.1.2 Asia Antipyretic and Analgesic Drugs Sales by Type (2021-2032)
  4. 11.1.3 Asia Antipyretic and Analgesic Drugs Price by Type (2021-2032)
  5. 11.2 Asia Antipyretic and Analgesic Drugs Market Size by Application
  6. 11.2.1 Asia Antipyretic and Analgesic Drugs Revenue by Application (2021-2032)
  7. 11.2.2 Asia Antipyretic and Analgesic Drugs Sales by Application (2021-2032)
  8. 11.2.3 Asia Antipyretic and Analgesic Drugs Price by Application (2021-2032)
  9. 11.3 Asia Antipyretic and Analgesic Drugs Market Size by Country
  10. 11.3.1 Asia Antipyretic and Analgesic Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Antipyretic and Analgesic Drugs Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Antipyretic and Analgesic Drugs Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Antipyretic and Analgesic Drugs Market Size by Type
  2. 12.1.1 SAMEA Antipyretic and Analgesic Drugs Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Antipyretic and Analgesic Drugs Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Antipyretic and Analgesic Drugs Price by Type (2021-2032)
  5. 12.2 SAMEA Antipyretic and Analgesic Drugs Market Size by Application
  6. 12.2.1 SAMEA Antipyretic and Analgesic Drugs Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Antipyretic and Analgesic Drugs Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Antipyretic and Analgesic Drugs Price by Application (2021-2032)
  9. 12.3 SAMEA Antipyretic and Analgesic Drugs Market Size by Country
  10. 12.3.1 SAMEA Antipyretic and Analgesic Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Antipyretic and Analgesic Drugs Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Antipyretic and Analgesic Drugs Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Antipyretic and Analgesic Drugs Value Chain Analysis
  2. 13.1.1 Antipyretic and Analgesic Drugs Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Antipyretic and Analgesic Drugs Production Mode & Process
  6. 13.2 Antipyretic and Analgesic Drugs Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Antipyretic and Analgesic Drugs Distributors
  9. 13.2.3 Antipyretic and Analgesic Drugs Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst